X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (767) 767
Publication (47) 47
Book Chapter (11) 11
Book Review (10) 10
Conference Proceeding (5) 5
Book / eBook (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (316) 316
index medicus (243) 243
hematology (233) 233
multiple myeloma (177) 177
female (171) 171
oncology (164) 164
male (163) 163
middle aged (154) 154
aged (145) 145
adult (119) 119
bortezomib (94) 94
multiple myeloma - drug therapy (93) 93
aged, 80 and over (89) 89
treatment outcome (62) 62
hematology, oncology and palliative medicine (61) 61
zoledronic acid (58) 58
multiple-myeloma (57) 57
multiple myeloma - complications (56) 56
cancer (54) 54
care and treatment (54) 54
prognosis (54) 54
survival (51) 51
lenalidomide (50) 50
antineoplastic agents - therapeutic use (48) 48
stem-cell transplantation (48) 48
antineoplastic combined chemotherapy protocols - therapeutic use (47) 47
dexamethasone (45) 45
multiple myeloma - pathology (45) 45
multiple myeloma - mortality (36) 36
thalidomide (36) 36
bisphosphonates (35) 35
diphosphonates - therapeutic use (34) 34
disease (34) 34
multiple myeloma - diagnosis (34) 34
osteoprotegerin (34) 34
analysis (33) 33
multiple myeloma - therapy (32) 32
therapy (32) 32
biomarkers - blood (30) 30
medicine & public health (29) 29
bone density conservation agents - therapeutic use (28) 28
osteoporosis (27) 27
survival analysis (26) 26
boronic acids - therapeutic use (25) 25
expression (25) 25
pyrazines - therapeutic use (25) 25
medical colleges (24) 24
receptor activator (24) 24
risk factors (24) 24
abridged index medicus (23) 23
bone disease (22) 22
denosumab (22) 22
multiple myeloma - blood (22) 22
diagnosis (21) 21
dickkopf-1 (21) 21
double-blind (21) 21
monoclonal gammopathy (21) 21
myeloma (21) 21
thalidomide - analogs & derivatives (21) 21
dexamethasone - administration & dosage (20) 20
medical research (20) 20
pharmacology & pharmacy (20) 20
bone diseases - etiology (19) 19
carfilzomib (19) 19
chemotherapy (19) 19
development and progression (19) 19
disease progression (19) 19
drug therapy (19) 19
patient outcomes (19) 19
angiogenesis (18) 18
health aspects (18) 18
multiple myeloma - metabolism (18) 18
recurrence (18) 18
retrospective studies (18) 18
risk (18) 18
thalidomide - administration & dosage (18) 18
bone markers (17) 17
disease-free survival (17) 17
endocrinology & metabolism (17) 17
imidazoles - therapeutic use (17) 17
kappa-b ligand (17) 17
magnetic resonance imaging (17) 17
pamidronate (17) 17
research (17) 17
thalassemia (17) 17
transplantation (17) 17
animals (16) 16
antineoplastic agents - adverse effects (16) 16
antineoplastic combined chemotherapy protocols - adverse effects (16) 16
lymphoma (16) 16
skeletal-related events (16) 16
survival rate (16) 16
collagen (15) 15
neoplasm staging (15) 15
patients (15) 15
bone resorption (14) 14
case-control studies (14) 14
cells (14) 14
drug therapy, combination (14) 14
follow-up studies (14) 14
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2018, Hematologic Malignancies, ISBN 9783319255842
This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of... 
Medicine | Immunology | Hematology | Oncology
Web Resource
American Journal of Hematology, ISSN 0361-8609, 05/2016, Volume 91, Issue 5, pp. 499 - 502
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. e328 - e346
Journal Article
Leukemia Research, ISSN 0145-2126, 2014, Volume 38, pp. S15 - S15
Journal Article
Clinical Lymphoma, Myeloma & Leukemia, ISSN 2152-2650, 2017, Volume 17, Issue 6, pp. 329 - 339
Journal Article
Clinical Lymphoma Myeloma and Leukemia, ISSN 2152-2650, 05/2018, Volume 18, Issue 5, pp. 321 - 334
The novel clinical data for myeloma that were presented in the 2017 Annual Meeting of the American Society of Hematology are summarized here. Studies with... 
Lenalidomide | Autologous transplantation | Smoldering myeloma | Daratumumab | Minmal residual disease | FINAL ANALYSIS | PHASE-II | OPEN-LABEL | MAINTENANCE THERAPY | ONCOLOGY | 1ST RELAPSE | STEM-CELL TRANSPLANTATION | RECEPTOR T-CELLS | PATIENTS PTS | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | LENALIDOMIDE MAINTENANCE
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 09/2013, Volume 88, Issue 9, pp. 765 - 770
Journal Article
Anti-Cancer Agents in Medicinal Chemistry, ISSN 1871-5206, 02/2012, Volume 12, Issue 2, pp. 123 - 128
Bisphosphonates inhibit osteoclast-mediated bone resorption and have been used extensively to prevent skeletal-related events in patients with bone lesions... 
Bone resorption | Angiogenesis | Immune response | Multiple myeloma | Clinical trials | Antitumor activity | Data processing | Dentistry | Bisphosphonates | Kidney | Apoptosis | Tumors
Journal Article
Journal Article